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16 Siderophores are produced by a number of microbes to capture iron with
17 outstandingly high afﬁnity, which property also generates biomedical and indus-
18 trial interests. Desferrioxamine E (DFO-E) secreted by streptomycetes bacteria can
19 be an ideal candidate for iron chelation therapy, which necessitates its cost-
20 effective production for in vitro and animal studies. This study focused on the
21 optimization of DFO-E production by Streptomyces parvulus CBS548.68. Differ-
22 ent combinations of various carbon and nitrogen sources as well as the addition of
23 3-morpholinopropane-1-sulfonic acid (MOPS) markedly affected DFO-E yields,
24 which were attributed, at least in part, to the higher biomass productions found in
25 MOPS-supplemented cultures. In MOPS-supplemented glucose and sodium
26 glutamate medium, DFO-E productions as high as 2,009 ± 90 mg/l of culture
27 medium were reached. HPLCQ2 analysis demonstrated that a simple two-step
28 puriﬁcation process yielded DFO-E preparations with purities of ∼97%.
29 MALDI-TOF mass spectrometry analysis showed that puriﬁed DFO-E always
30 contained traces of desferrioxamine D2.
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32 Introduction
33 Siderophores are iron chelators produced by many microorganisms to
34 sequester iron from the environment [1]. These compounds bind iron with
35 remarkably high afﬁnity and, hence, they are pivotally important in supporting
36 the growth of microbes and are also required in the invasion of host organisms by
37 many pathogens [2]. Although iron is an abundant element on Earth, its bioavail-
38 ability is considerably limited in the environment by the low solubility of Fe3+
39 (∼10−24 mol/l) [3–5].
40 Some soil bacteria like the Gram-positive Streptomyces species produce
41 commercially important antibiotics and other metabolites like iron-chelator side-
42 rophores, e.g., desferrioxamine B (DFO-B), a product of Streptomyces pilosus,
43 which is employed to treat iron overload in humans [6]. Iron chelators are
44 routinely used for the medication of the patients with iron overloads like in the
45 case of β-thalassemia or sickle cell disease [7, 8]. Several studies have demon-
46 strated that DFO-B is able to mitigate oxidative cell damages in various biological
47 systems through disrupting iron-mediated redox cycling reactions [9–11]. Hartley
48 et al. [11] also showed that DFO-B itself can act as a radical scavenger by donating
49 an electron or hydrogen atom from the hydroxamate center. Therefore, side-
50 rophores of both bacterial and fungal origins are considered in the prevention and
51 treatment of oxidative-stress-mediated diseases, e.g., ischemia–reperfusion injury
52 diabetes, inﬂammation, and atherosclerosis [12–16]. Not surprisingly, there is also
53 an increasing body of evidence that these siderophores are able to target cancer
54 cells selectively [17, 18].
55 In a recent study published by Todokoro et al. (2015), a promising
56 new application was described for the natural hexadentate iron chelator
57 deferriferrichrysin, fermented by the rice-saccharifying fungus Aspergillus
58 oryzae as a food-grade antioxidant [19]. FurthermoreQ3 , Shimoni et al. (1998)
59 demonstrated that the hexadentate cyclic siderophore desferrioxamine E (DFO-E,
60 also produced by various streptomycetes) possessed signiﬁcant antioxidant
61 effects in linoleic acid and also in combined linoleic acid–β-carotene
62 emulsions.
63 These results suggest that various siderophores of microbial origin, includ-
64 ing DFO-E, could be candidate drugs to medicate oxidative-stress-or iron-excess-
65 mediated diseases in humans. Because today’s knowledge on the optimization of
66 microbial siderophore productions is still rather uneven, further studies are
67 deﬁnitely needed to introduce new fermentation processes for the more cost-
68 effective production of microbial siderophores like DFO-E, e.g., for in vitro and
69 animal studiesQ4 [20, 21].
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70 Materials and Methods
71 Chemicals
72 D-Glucose monohydrate, agar, K2HPO4, NaCl, methanol, chloroform, ace-
73 tonitrile (HiPerSolv CHROMANORM, isocratic grade for HPLC), and glycerol
74 were purchased from VWR BDH Prolabo (VWR, Radnor, PA, USA); yeast
75 extract and FeCl3·6H2O from Alfa Aesar (Ward Hill, MA, USA); L-aspartic acid
76 (L-Asp), Amberlite XAD-2, Na-L-glutamate (monosodium salt monohydrate),
77 3-morpholinopropane-1-sulfonic acid (MOPS), and ZnSO4·7H2O from Sigma-
78 Aldrich (St. Louis, MO, USA); anhydrous MgSO4, Silica Gel 60, and soluble
79 starch from Merck (Darmstadt, Germany); CaCO3 and K2SO4 from Reanal
80 (Budapest, Hungary); and malt extract from Oxoid (Basingstoke, UK), while
81 anhydrous CaCl2 was bought from Scharlau (Barcelona, Spain).
82 Production and harvesting of spores
83 S. parvulus CBS 548.68 was cultured on glucose–yeast extract–malt extract
84 (GYM) Streptomyces medium (pH 7.2), containing 4.0 g/l glucose, 4 g/l yeast
85 extract, 10 g/l malt extract, 2.0 g/l CaCO3, and 12 g/l agar. After incubation at 28 °C
86 for 9 days, spores were harvested by agitation in sterile 0.9% NaCl solution
87 supplemented with 0.1% Tween-80. Spore suspensions were passed through
88 sterile cotton wool and centrifuged at 12,000 × g for 2 min at room temperature,
89 washed with distilled water, centrifuged again, and stored in 20% glycerol at −20 °C.
90 Colony-forming units (CFU) were determined by streaking a limited dilution of
91 spores on GYM Streptomyces medium and incubated at 28 °C for 5 days.
92 Siderophore production
93 All glasswares were rinsed with 36% HCl and were washed subsequently
94 with distilled water to remove any residual iron. Siderophore production was
95 carried out in glass Erlenmeyer ﬂasks (250 ml) containing 50 ml aliquots of
96 production medium, which were inoculated with 1.9 × 108 CFU spores from
97 glycerol stock, and were incubated at 28 °C and at 4.2-Hz shaking frequency. The
98 basic siderophore production medium (pH 7.5) contained 5 g/l L-Asp or
99 Na-L-glutamate monosodium salt monohydrate (Na-L-Glu), 5 g/l L-lysine
100 monohydrochloride (L-Lys), 2 g/l K2HPO4, 2 g/l K2SO4, 1 g/l NaCl, 0.1 g/l
101 anhydrous CaCl2, 0.2 g/l anhydrous MgSO4, 0.1 g/l ZnSO4·7H2O, and 2.5%
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102 carbon source (glucose, glycerol, or soluble starch). The buffered siderophore
103 production medium contained the same ingredients as the basic medium, but it was
104 also supplemented with 21 g/l MOPS and autoclaved for 15 min at 121 °C. Carbon
105 sources were autoclaved separately as 25% stock solutions. In order to determine
106 the siderophore productions by different cultures, 1.0 ml of production medium
107 samples were taken at 72-, 96-, and 120-h incubation times after inoculation.
108 Samples were centrifuged at 14,000 × g for 5 min at room temperature, and then,
109 supernatants from each ﬂasks (500 μl) were transferred to 1.5-ml Eppendorf tubes
110 and supplemented with 20 μl of 10% FeCl3·6H2O to saturate all produced
111 siderophores with iron before HPLC analysis. The effects of the carbon source,
112 nitrogen source, and MOPS were evaluated with variance analysisQ5 (ANOVA), and
113 Tukey’s difference test using the R 2.3.1 software (The R Development Core
114 Team; http://www.r-project.org/) was adapted to describe the response surface
115 (Lee and Chen 1997).
116 HPLC analysis
117 HPLC measurements were carried out with a HP 1090 liquid chromato-
118 graph, equipped with autosampler and diode array detector. Ferrioxamines were
119 separated on a mixed-phase column (Luknova Hyper SCX 4.6 mm × 100 mm,
120 5 μm), in which both the cation exchange and hydrophobic interactions contrib-
121 ute to the separation. The 10-μl injected sample was separated by isocratic elution
122 with 1:4 acetonitrile: 0.5 M NaCl solvent mixture at 0.5 ml/min ﬂow rate.
123 Siderophores were detected at λ= 435 nm, and Agilent ChemStation was used to
124 evaluate the chromatograms. Commercially available, ferrated DFO-E was used
125 as standard.
126 Puriﬁcation of siderophores with column chromatography
127 Culture media of S. parvulus (V= 1,000 ml, incubation time= 96 h) were
128 centrifuged at 4,000 × g for 20 min at 4 °C, and the supernatants were
129 supplemented with 2 g/l of FeCl3·6H2O to reach iron complexation of all side-
130 rophores. Ferrated siderophores were isolated ﬁrst using Amberlite XAD2 resin
131 and were puriﬁed further with Silica Gel 60 chromatography with a chloroform:
132 methanol:water (17.5:6:1) solvent mixture as the mobile phase. Organic solvents
133 were evaporated with a Buchi Rotavapor R-3000 equipment. Following that, the
134 ferrated DFO-E was dissolved in distilled water and analyzed with HPLC, and the
135 two fractions detected with HPLC were analyzed with MALDI-TOF mass
136 spectrometry (MS).
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137 MALDI-TOF MS
138 HPLC fractions of the puriﬁed siderophores were analyzed with MALDI-
139 TOF MS in positive-ion mode using a Bruker Biﬂex MALDI-TOF mass
140 spectrometer equipped with delayed-ion extraction. Desorption/ionization of
141 the sample molecules was performed with a λ = 337 nm nitrogen laser, and
142 2,5-dihydroxy benzoic acid was used as matrix. Spectra from multiple (at least
143 100) laser shots were summarized using 19-kV accelerating and 20-kV
144 reﬂectron voltage. External calibration was applied using the [M + Na] +
145 peaks of cyclodextrinsQ6 DP 6–8 with m/z: 995 Da, m/z: 1,157 Da, and m/z:
146 1,319 Da, respectively.
147 Response surface methodology (RSM)
148 The optimal medium composition for DFO-E production was determined
149 using the RSM with two selected variables (Na-L-Glu and L-Lys concentra-
150 tions) with the central composite design and full-factorial design consisting of
151 two-factor-two-level pattern with 11 design points (nine combinations with
152 three replications of the center points). In accordance with our preliminary
153 experiments, DFO-E yields depended highly on L-Lys and Na-L-Glu concen-
154 trations. Two plausible variables, glucose and MOPS concentrations, were
155 omitted from the analysis since neither increasing glucose concentration from
156 25 g/l to 50 g/l nor decreasing to 10 g/l, or decreasing MOPS concentration
157 from 21 g/l to 15 g/l or 10 g/l did not affect the DFO-E yields considerably,
158 while decreasing either L-Lys or Na-L-Glu from 5 g/l to 2.5 g/l reduced DFO-E
159 yields by 20%–40% (data not shown). A full second-order polynomial model
160 was obtained by a multiple regression technique for two factors using the R
161 2.3.1 software.
162 Results
163 Identiﬁcation of DFO-E produced by S. parvulus
164 When culture media supplemented with Fe(III) were subjected to HPLC
165 analysis, four clearly distinguishable peaks were identiﬁed in each fermentation
166 medium. Two of them, observed at ∼3.5-min and ∼4.4-min retention times, had
167 the same retention values as the DFO-B and DFO-E standards, respectively (data
168 not shown).
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169 HPLC and MALDI-TOF MS analysis of the puriﬁed DFO-E
170 The purity of DFO-E prepared from the culture supernatant of S. parvulus
171 after Amberlite XAD and Silica Gel puriﬁcation was checked with HPLC, and
172 approximately 97% of the siderophore content was DFO-E (∼4.5-min retention
173 time, Peak 2 in Figure 1A). A minor siderophore peak always appearing at 4.1-min
174 retention time in all preparations (Peak 1 in Figure 1A) was identical to
175 desferrioxamine D2 (DFO-D2). The chemical structures of DFO-E and DFO-
176 D2 were veriﬁed by MALDI-TOF MS analyses (Figure 1B and C).
177 Inﬂuence of MOPS as well as various carbon and nitrogen sources on biomass
178 and siderophore yields
179 In unbuffered culture media, DFO-E production reached its maximum at 96-h
180 incubation time after inoculation, and it remained constant or even slightly
181 decreased following that (Figure 2). The highest DFO-E production was detected
182 in the glucose+Na-L-Glu medium followed by glucose+ L-Asp and glycerol+
183 Na-L-Glu media, while the glycerol+ L-Asp medium showed slightly decreased
184 yields. Starch was not a favored carbon source either in L-Asp- (96± 3 mg/l) or in
185 Na-L-Glu- (99± 2 mg/l) supplemented media, which may indicate that the positive
186 effect of Na-L-Glu is dependent on the nature of carbon source (Figure 2). On the
187 other hand, MOPS supplementation markedly increased DFO-E yields in the
188 presence of all carbon and nitrogen sources and their combinations tested
189 (Figure 2).
190 In MOPS-buffered media, DFO-E production reached its peak at 120 h after
191 inoculation, and the most beneﬁcial effects of MOPS on DFO-E yields were
192 recorded in the presence of starch, where 7- to 9-fold increases in DFO-E
193 productions were recorded when compared with unbuffered systems (from 96
194 ± 3 mg/l to 882± 179 mg/l in starch+ L-Asp and from 99± 2 mg/l toQ8 715± 34 99
195 ± 2 mg/l in starch+Na-L-Glu media). The maximum DFO-E yield (1,390±
196 65 mg/l) was detected in MOPS-buffered glucose+Na-L-Glu medium (Figure 2).
197 The ﬁnal pH of the fermentation media for all tested combinations (includ-
198 ing media with MOPS) was slightly acidic (pH 5.3–6.2) except starch+ L-Asp
199 (pH 8.1) and starch+Na-L-Glu (pH 7.1). Dry cell masses correlated well with
200 yields with the exception of unbuffered starch+ L-Asp and starch+Na-L-Glu
201 media (Figure 2 and Table I). Surprisingly, the ﬁnal biomass gains found in
202 MOPS-buffered starch+ L-Asp and MOPS-buffered glucose-Na-L-Glu media
203 were comparable (7.9 g/l and 8.9 g/l, respectively), but the DFO-E yields recorded
204 in these systems differed considerably. In MOPS-buffered Na-L-Glu supplemented
6 GÁLL ET AL.
Acta Microbiologica et Immunologica Hungarica
Figure 1. HPLC and MALDI-TOF MS analysis of the puriﬁed DFO-EQ7
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Figure 2. Fitted regression surface showing Na-L-Glu and L-Lys dependence of DFO-E production
Table I. Effect of MOPS, carbon source, and nitrogen source on dry cell mass. MOPS supplementation
markedly increased dry cell mass compared with the unbuffered mediaQ9
DFO-E production
medium
Dry cell mass at 72-h
incubation (g/l)
Dry cell mass at 96-h
incubation (g/l)
Dry cell mass at 120-h
incubation (g/l)
Glucose+ aspartic acid 2.2± 0.2 2.3± 0.2 2.4± 0.2
Glucose+ aspartic acid
+MOPS
4.2± 0.1 4.7± 0.2 4.7± 0.2
Glycerol+ aspartic acid 2.6± 0.1 2.6± 0.1 2.7± 0.1
Glycerol+ aspartic acid
+MOPS
5.4± 0.5 6.2± 0.6 6.4± 0.4
Starch+ aspartic acid 2.2± 0.1 2.8± 0.1 2.8± 0.1
Starch+ aspartic acid+
MOPS
4.7± 0.2 6.3± 0.5 7.9± 0.3
Glucose+ glutamic acid 5.2± 0.1 5.3± 0.1 5.5± 0.1
Glucose+ glutamic acid
+MOPS
5.5± 0.3 8.1± 0.2 8.9± 0.1
Glycerol+ glutamic acid 3.5± 0.3 3.5± 0.2 3.7± 0.2
Glycerol+ glutamic
acid+MOPS
5.8± 0.5 8.1± 0.2 8.4± 0.4
Starch+ glutamic acid 2.3± 0.1 2.3± 0.1 2.4± 0.1
Starch+ glutamic acid+
MOPS
6.0± 0.3 6.2± 0.3 7.9± 0.2
Note: Results are shown as mean values of three independent experiments with standard deviations.
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205 media, all the glucose, glycerol, and starch carbon sources resulted in high growth
206 rates, but siderophore productions varied again within a relatively wide range
207 (Figure 2 and Table I).
208 According to ANOVA, the effects of carbon sources, nitrogen sources, and the
209 presence of MOPS on DFO-E productions were signiﬁcant (Table II). On the other
210 hand, there was no signiﬁcant difference between taking samples at 96-h or 120-h
211 incubation times, but DFO-E concentrations recorded at 72-h incubation time were
212 signiﬁcantly lower than those found at 120-h or 96-h incubations. According to the
213 Tukey’s difference test, the DFO-E contents of media containing glucose, glutamic
214 acid, and MOPS incubated for 120 h were signiﬁcantly higher (adjusted p< 0.05)
215 than those found in other cultures at any incubation times tested, except the glucose,
216 glutamic acid, and MOPS containing cultures when incubated for 96 h (Supplemen-
217 tary Material).
218 Optimization of Na-L-Glu and L-Lys concentrations in DFO-E production
219 using RSM
220 To describe the optimal medium for DFO-E production with S. parvulus, the
221 response surface was studied as a function of Na-L-Glu and L-Lys concentrations
222 as described earlier [22]. Glucose and MOPS levels in the fermentation media
223 were set to the concentrations (25 g/l for glucose and 21 g/l for MOPS) used before
224 for the optimization of the carbon and nitrogen sources. The levels for initial
225 Na-L-Glu and L-Asp concentrations as well as experimental data for the
Table II. ANOVA of DFO-E production data
Variable Difference in DFO-E production (mg/l) Adjusted p values
Effect of carbon source
Glycerol–glucose −175.75 <0.000001
Starch–glucose −372.99 <0.000001
Starch–glycerol −197.24 <0.000001
Effect of nitrogen source
Glutamic acid–aspartic acid 202.18 <0.000001
Effect of MOPS
Without MOPS–with MOPS −441.32 <0.000001
Effect of sample taking
72–120 h −178.13 <0.000001
96–120 h −35.49 0.26
96–72 h 142.64 <0.000001
Note: According to ANOVA, the effects of carbon source, nitrogen source, and the presence of MOPS were
signiﬁcant. There was no signiﬁcant difference between 96-h and 120-h sample taking, but at 72 h, the DFO-E
concentrations were signiﬁcantly lower than at 120 h or at 96 h.
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226 two-factor-two-level response surface analysis are summarized in Table III. Three
227 repeats were included at the center of the design, and the total number of the test
228 runs was 11. Regression coefﬁcients, their t values, and determination coefﬁcient
229 (R2) for the full second-order polynomial model of DFO-E production are
230 presented in Table IV. The regression model for DFO-E production was signiﬁ-
231 cant (p= 0.01912) with a satisfactory value of R2 (0.89). The estimated DFO-E
232 production at optimal Na-L-Glu (12.96 g/l) and L-Lys (13.60 g/l) concentrations
233 was 2,130 mg/l, which corresponded well with the measured 2,009± 90 mg/l
234 DFO-E production (n= 3) at 13 g/l Na-L-Glu and 14 g/l L-Lys concentrations.
Table III. Experimental data of the central composite and full-factorial design
Na-L-Glu (g/l) L-Lys (g/l) Coded valuesa DFO-E (g/l)
Trial X1 X2 Z1 Z2 Y
1 6 6 −1 −1 1.7
2 6 14 −1 1 1.6
3 14 6 1 −1 1.7
4 14 14 1 1 2.0
5 15.66 10 1.414 0 2.0
6 4.34 10 −1.414 0 1.5
7 10 15.66 0 1.414 2.1
8 10 4.34 0 −1.414 1.6
9 10 10 0 0 2.1
10 10 10 0 0 2.0
11 10 10 0 0 2.0
Note: The glucose content of the medium was set to 25 g/l, while MOPS to 21 g/l, and DFO-E production
was quantiﬁed after 120 h of cultivation.
aZi= (Xi− 10)/4.
Table IV. Regression of coefﬁcients, p values, determination coefﬁcient (R2), and F-statistic of a full
second-order polynomial model for DFO-E productionQ10
TermQ11 a Coefﬁcient p value
b0 2.033 4.524× 10−7
b1 0.138 0.01383
b2 0.113 0.02871
b12 0.100 0.11637
b11 −0.154 0.01777
b22 −0.104 0.06578
R2= 0.89
F-statistic: 8.124 (DF 5 and 5), p value= 0.01912
aY= b0+ b1Z1+ b2Z2+ b11Z12+ b12Z1Z2+ b22Z22, where Y is DFO-E (g/l) production, and Z1 and Z2 are
Na-L-Glu and L-Lys content of the media (given in coded values), respectively.
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235 Discussion
236 There is a plethora of evidence that the types of carbon sources and nitrogen
237 sources as well as other culture media supplements (salts and precursors) greatly
238 inﬂuence secondary metabolite biosyntheses, e.g., siderophore [20, 23–25]. In
239 good accordance with this, different combinations of carbon sources, nitrogen
240 sources, and MOPS resulted in various DFO-E yields during the production of this
241 hexadentate cyclic siderophore by S. parvulus.
242 In unbuffered systems, i.e., when MOPS was not supplemented, the gains in
243 biomasses recorded in starch+ L-Asp and starch+Na-L-Glu media were similar to
244 those found in glucose+ L-Asp and glycerol+ L-Asp media, but DFO-E yields
245 were considerably higher in the latter cases (Table I). The lower DFO-E yields
246 detected in unbuffered starch systems may be explained by the neutral or even
247 slightly alkaline pH of the fermentation media (pH 7.1 for the starch+Na-L-Glu
248 and pH 8.1 for the starch+ L-Asp media). It is worth noting that even in the
249 presence of MOPS, the ﬁnal pH values measured in most tested culture media
250 were slightly acidic (pH 5.3–6.2), and it is well established that hydroxamate-type
251 siderophores are most stable under acidic conditions [26]. Szigeti et al. [27] also
252 found that triacetylfusarinin C production by the opportunistic human pathogenic
253 fungus Aspergillus fumigatus also favored acidic conditions. Because culture
254 media underwent acidiﬁcation even in the presence of MOPS and DFO-E yields
255 were not affected by decreasing MOPS concentration from 21 g/l to 10 g/l, we can
256 conclude that the positive effects of MOPS on DFO-E yields cannot be attributed
257 solely to its buffering effects in the culture media.
258 The addition of MOPS is likely to facilitate DFO-E productions through
259 supporting higher biomass productions (Table I) because dry cell masses corre-
260 lated well with DFO-E yields when siderophore productions in MOPS-buffered
261 and not buffered media were compared (Figure 2 and Table I). On the other hand,
262 the improved yields could not be explained exclusively with the increased biomass
263 gains because various DFO-E productions were observed in MOPS-buffered
264 Na-L-Glu media supplemented with different carbon sources (glucose, glycerol,
265 and starch), meanwhile the biomasses measured at 120-h incubation times
266 were quite similar (Table I). Hence, further experiments are needed to shed light
267 on the mechanism(s) through which MOPS stimulates DFO-E production in
268 S. parvulus.
269 Considering the beneﬁcial effects of the nitrogen sources on siderophore
270 yields, the positive effect of L-Lys on DFO production is well known because
271 L-Lys, the precursor of DFOs, greatly enhances their productions [20, 21]. As shown
272 above, Na-L-Glu also stimulated the biomass production and the biosynthesis of
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273 DFO-E by S. parvulus in both MOPS-buffered and unbuffered systems with the
274 exception of media containing starch as carbon source (Figure 2 and Table I). In the
275 absence of MOPS, starch-containing media supplemented with either L-Lys or Na-L-
276 Glu as nitrogen sources provided us with comparable biomass and DFO-E yields
277 (Figure 2 and Table I). These data indicated that both siderophore yields and biomass
278 gains were inﬂuenced by the carbon source as well, and the beneﬁcial effect of Na-L-
279 Glu was carbon source dependent. Similar phenomena were also observed when
280 MOPS was also added to the culture media (Figure 2).
281 After optimizing the Na-L-Glu (14 g/l) and L-Lys (13 g/l) concentrations in
282 glucose (25 g/l) and MOPS (21 g/l) containing fermentation medium, S. parvulus
283 CBS548.69 provided us with DFO-E in considerable yields (∼2 g/l). Following
284 that high purity grade (∼97%), DFO-E preparations were obtained in a simple
285 two-step puriﬁcation scheme relying on the capture of DFO-E by XAD resin and
286 silica gel chromatography (Figure 1A–C). MALDI-TOF MS demonstrated that
287 puriﬁed DFO-E always contained traces of DFO-D2 (Peak 1 in Figure 1A).
288 There are plenty of experimental data available on the optimization of the
289 production of hydroxamate-type hexadentate siderophores of microbial origin,
290 including compounds produced by either fungi (coprogen, ferrichrysin, and
291 triacetylfusarinin C) [22, 27, 29] or bacteria [23, 30]. Considering yields,
292 maximum coprogen productions by the ﬁlamentous fungus Neurospora crassa
293 varied between 200 mg/l and 250 mg/l, meanwhile triacetylfusarinin C production
294 by A. fumigatus reached as high as 2.9 g/l [22, 27, 29]. Todokoro et al. [19]
295 demonstrated that ferrichrysin production by A. oryzae can even reach 2.8 g/l.
296 Furthermore, Mortazavi and AkbarzadehQ12 reported on almost 2 g/l DFO-B yields
297 with S. pilosus ATCC 19797, and Chiani et al. [25] published a 5 g/l DFO-B
298 production with the same streptomycete by adding Na2HPO4·12H2O, NaH2PO4,
299 MgSO4·7H2O, ZnSO4·7H2O, FeSO4·7H2O, CaCl2·2H2O, NaCl, MnSO4, NH4Cl,
300 KH2PO4, and K2HPO4 to the medium.
301 Not surprisingly, although production data for DFO-B [25, 28, 31] are
302 abundant because this siderophore is widely used for the treatment of iron
303 overload in humans, similar data for the optimization of DFO-E production are
304 scarcely available [20, 21]. Nevertheless, the highest DFO-E yield was reported by
305 Meiwes et al. [21], which reached 12 g/l in a fed-batch fermentation system with
306 Streptomyces olivaceus TÜ 2718. Although this yield is six times higher than the
307 highest DFO-E production by S. parvulus recorded in this study, there are
308 arguments for considering S. parvulus, when future DFO-E production technolo-
309 gies will be developed, at least at laboratory scale. For example, the S. parvulus
310 CBS 548.68 strain used in this study is commercially available and the shaking
311 ﬂask method reported here may be scaled up simply in bench-top bioreactors [22].
312 Importantly, the favorable effects of MOPS on DFO-E production can be tested
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313 and, hopefully, also exploited in any other chemically deﬁned fermentation media
314 currently applied in siderophore productions [22, 27, 29].
315 We hope that our results will enable us to carry out further experiments to
316 reveal the complexometric properties, cytotoxicity, and physiological/pharmaco-
317 logical characteristics of this DFO-E. Large-scale production of various side-
318 rophores would make many potential applications of these iron chelators possible
319 in the future, e.g., in managing human diseases like atherosclerosis, imaging
320 fungal infections, or preparing siderophore–antibiotic conjugates [16, 32, 33].
321 Other possible applications of siderophores include the prevention of post-harvest
322 diseases in stored crops, fruits, and vegetables or using siderophores as food-grade
323 antioxidants or in heavy metal bioremediation technologies [19, 34–36]. There-
324 fore, we need further studies to set up efﬁcient and proﬁtable technologies for the
325 bulk production of these promising compounds.
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